PMC:7200337 / 98633-98839
Annnotations
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1024 | 36-37 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T1025 | 61-66 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T1026 | 116-117 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T320 | 134-136 | Chemical | denotes | VH | http://purl.obolibrary.org/obo/CHEBI_73700 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3283 | 47-49 | Gene | denotes | to | Gene:6999 |
3286 | 61-66 | Species | denotes | human | Tax:9606 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T579 | 0-206 | Sentence | denotes | In one study, the authors developed a protocol to synthetize human nanobodies, smaller antibodies that only contain a variable heavy (VH) chain as first described in camelids (Wu et al., 2020c) (Figure 6D). |